A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors

NCT06537310 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer-Neoplasms

Interventions

DRUG: RO7567132 and Atezolizumab
DRUG: RO7567132 and Atezolizumab

Sponsor

Hoffmann-La Roche